Teva Pharmaceuticals USA announced the availability of Ursodiol Capsules USP, 300 mg. The product is AB rated and bioequivalent to Novartis Corp.'s Actigall and is available in bottles of 100. "With the contributions from Teva USA's strong research and development efforts and our extensive manufacturing capacity, our customers can continue to expect a growing line of new quality generic pharmaceuticals," said Bill March, vice president of sales and marketing.
COPYRIGHT 2000 Lebhar-Friedman, Inc.
COPYRIGHT 2000 Gale Group